Mary-Kathryn Canning, MBA

Results-driven and highly agile Program Management leader with strong business acumen, Clinical Operations background and experience leading cross-functional teams from IND through late-stage clinical development and BLA readiness. As “Program COO”, proven ability to lead program planning and execution, enable exceptional team performance in fast-paced environments, develop and execute strategic initiatives and effectively manage stakeholders at all levels of an organization. Skilled in developing fit-for-purpose tools and bespoke visualizations to enable milestone tracking, organizational reporting and support decision-making, enabling leaders and team members to focus on what really matters. Broad therapeutic area experience includes cardiovascular drug and device, diabetes, neurology, hematologic rare disease, (sickle cell, beta thalassemia), and neuromuscular rare disease (Duchenne Muscular Dystrophy).